OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and sample collection devices in the United States, Europe, and internationally. The company is headquartered in Bethlehem, Pennsylvania.
| Revenue (TTM) | $115.02M |
| Gross Profit (TTM) | $48.20M |
| EBITDA | $-57.43M |
| Operating Margin | -61.10% |
| Return on Equity | -18.30% |
| Return on Assets | -9.58% |
| Revenue/Share (TTM) | $1.56 |
| Book Value | $4.84 |
| Price-to-Book | 0.63 |
| Price-to-Sales (TTM) | 1.84 |
| EV/Revenue | 0.233 |
| EV/EBITDA | 4.32 |
| Quarterly Earnings Growth (YoY) | 29.60% |
| Quarterly Revenue Growth (YoY) | -28.50% |
| Shares Outstanding | $69.13M |
| Float | $60.64M |
| % Insiders | 6.78% |
| % Institutions | 89.80% |